title: Responsible conduct in nanomedicine research: environmental concerns beyond the common rule.
abstract: Nanomedicine research raises ethical concerns beyond those covered by the Common Rule. Investigators and research institutions should comply with environmental and occupational health laws protect research staff and the environment. Though the IRB should concentrate on risks to human research participants, it should also consider risks to identifiable third parties. Investigators should also address risks to identifiable third parties. Professional and governmental organizations should deal with the long-term social, ethical, and environmental consequences of nanomedicine.
authors.affiliation: National Institute of Environmental Health Science, National Institutes of Health, USA.
authors.forename: David B
authors.initials: DB
authors.lastname: Resnik
mesh_terms: D002986:Clinical Trials as Topic / Q000941:ethics*; D004781:Environmental Exposure / Q000517:prevention & control*; D028744:Ethics Committees, Research; D033161:Government Regulation; D006801:Humans; D008318:Malpractice / Q000331:legislation & jurisprudence; D050997:Nanomedicine / Q000941:ethics*; D049329:Nanostructures / Q000009:adverse effects; D016273:Occupational Exposure / Q000517:prevention & control; D011634:Public Health; D012308:Risk Management / Q000941:ethics / Q000331:legislation & jurisprudence / Q000379:methods; D012941:Social Responsibility; D014481:United States